索氨酸杀死Mycobacterium结核病通过阻断阿拉比南的合成
Vadim Makarov1, Giulia Manina, Katarina Mikusova
1A. N. Bakh Institute of Biochemistry, Russian Academy of Science, 119071 Moscow, Russia.
概括
新的丁酸 (BTZ) 通过向细胞壁合成中的关键酶来杀死结核病细菌. 化合物BTZ043在治疗药物敏感性和耐药性结核病方面表现有前途.
科学领域:
- 药用化学 医学化学
- 微生物学 微生物学
- 药物发现 药物发现 药物发现
背景情况:
- 结核病 (TB) 仍然是一个全球性卫生挑战,需要新的治疗药物.
- 现有的治疗方法面临抗药性挑战,需要新的药物类别.
研究的目的:
- 合成和描述1,3-二-4- (BTZs) 作为一种新型的抗菌菌剂.
- 确定BTZs的分子标并阐明它们对抗Mycobacterium tuberculosis的作用机制.
主要方法:
- 1,3-二-4-的合成和化学表征.
- 结核病在小鼠模型中的体外,体外和体内疗效研究.
- 基因和生化方法来识别药物标.
主要成果:
- 1,3-二-4-显示出对Mycobacterium tuberculosis的强有力的抗菌活性.
- 确定了decaprenylphosphoryl-beta-d-ribose 2'-epimerase作为BTZs的主要向酶.
- 抑制这种酶会破坏阿拉比南的合成,导致细胞溶解和细菌死亡.
结论:
- BTZs代表了一个有前途的新类抗菌菌药物.
- 确定的行动机制为结核病药物开发提供了新的策略.
- BTZ043是针对药物敏感性和广泛耐药性结核病的组合治疗的潜在候选者.
相关概念视频
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...

